The Tiny Cargo Company ("Tiny Cargo") and Bio-Sourcing SA (‘Bio-Sourcing’) today announced a strategic partnership to develop ...
--Findings support the versatility of Capricor’s exosome technology, enabling efficient and scalable loading of siRNAs and PMOs to support future clinical development-- The poster titled, “A ...
Exosomes, naturally derived vesicles responsible for intercellular communication, are emerging as next-generation drug delivery systems capable of transporting therapeutics to specific cells. However, ...
Liège-based Bio‑Sourcing and Roanoke-based The Tiny Cargo Company inked a strategic collaboration to co‑develop orally delivered monoclonal antibody (mAb)-based therapies formulated using goat ...
US alliance to accelerate next‑generation oral monoclonal antibody therapiesLiège, Belgium, and Roanoke (VA), USA, March 18, 2026 — Bio‑Sourcing SA (‘Bio-Sourcing’) and The Tiny Cargo Company (‘Tiny ...
The exosome therapies market is expected to experience significant growth due to increased interest in regenerative medicine, cancer treatments, and drug delivery systems. Leading Indications with ...
--Findings support the versatility of Capricor’s exosome technology, enabling efficient and scalable loading of siRNAs and PMOs to support future clinical development-- SAN DIEGO, Nov. 24, 2025 (GLOBE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results